Gelteq GELS
NASDAQ GELS
$0.56 +0.01 (+0.93%)
As of: Aug 21, 2026 · 3:26 PM EDT

Gelteq (GELS) Liabilities and Shareholders Equity (2023 - 2025)

Gelteq (GELS) posted quarterly Liabilities and Shareholders Equity of $13.2 million for Q4 2025, down 19.55% year-over-year from $16.4 million in Q4 2024, and down 3.92% quarter-over-quarter from $13.8 million in Q2 2025.

Gelteq (GELS) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends

Gelteq's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $13.2 million for Q4 2025.

  • In Q4 2025, Liabilities and Shareholders Equity fell 19.55% year-over-year to $13.2 million; the TTM figure through Dec 2025 stood at $57.1 million (up 26.44% YoY), while the FY2025 annual figure was $13.8 million, up 0.54% from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 stood at $13.2 million, down from $13.8 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $16.4 million in Q4 2024, with the low at $13.2 million in Q4 2025.
  • The 3-year median for Liabilities and Shareholders Equity is $13.8 million (2025), against an average of $14.4 million.
  • Peak annual rise in Liabilities and Shareholders Equity reached 0.54% in 2025, while the deepest fall reached 19.55% in 2025.
  • Gelteq's Liabilities and Shareholders Equity stood at $15.0 million in 2023, then rose by 9.24% to $16.4 million in 2024, then declined by 19.55% to $13.2 million in 2025.
  • Business Quant data shows GELS's Liabilities and Shareholders Equity at $13.2 million in Q4 2025, $13.8 million in Q2 2025, and $16.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 39.86 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 6.18 Bn
10 Gelteq 5.90 Mn 5.63 Mn - 13.21 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 13.21 Mn
Jun 30, 2025 13.75 Mn
Dec 31, 2024 16.42 Mn
Jun 30, 2024 13.68 Mn
Jun 30, 2023 15.03 Mn